项与 PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3 相关的临床试验
ChiCTR2500096689
/ Suspended临床2期IIT
Evaluation of efficacy and safety of pazopanib combined with TGI/CIV(nab?Paclitaxel+ gemcitabine + isocyclophosphamide/cyclophosphamide +Irinotecan + vinorelbine) in the treatment for children or adolescents with recurrent/refractory rhabdomyosarcoma ——an open-label, single-arm, single-center,phase II clinical trial
开始日期2025-03-01
申办/合作机构-
100 项与 PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3 相关的临床结果
登录后查看更多信息
100 项与 PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3 相关的转化医学
登录后查看更多信息
0 项与 PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3 相关的专利(医药)